wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26851183-43C675CA-1D60-42B9-BE76-13D26A6793C7
Q26851183-43C675CA-1D60-42B9-BE76-13D26A6793C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851183-43C675CA-1D60-42B9-BE76-13D26A6793C7
Anti-angiogenesis in prostate cancer: knocked down but not out
P2860
Q26851183-43C675CA-1D60-42B9-BE76-13D26A6793C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851183-43C675CA-1D60-42B9-BE76-13D26A6793C7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4988807834be913478bcf0774f44cb059c38bde8
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.